Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1986 Feb;79(2):96–99. doi: 10.1177/014107688607900210

Development of new drugs in man: a review.

I B Davies, I M Grind, A Pottage, P Turner
PMCID: PMC1290191  PMID: 3512825

Full text

PDF
96

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alloza J. L., Lasagna L. A comparison of drug product information in four national compendia. Clin Pharmacol Ther. 1983 Mar;33(3):269–277. doi: 10.1038/clpt.1983.32. [DOI] [PubMed] [Google Scholar]
  2. Andrews P. A., Thompson G. M., Ward C. A regulatory view of the Medicines Act in the United Kingdom. J Clin Pharmacol. 1984 Jan;24(1):6–18. doi: 10.1002/j.1552-4604.1984.tb01808.x. [DOI] [PubMed] [Google Scholar]
  3. Aronson J. K., Grahame-Smith D. G. Clinical pharmacology. Adverse drug interactions. Br Med J (Clin Res Ed) 1981 Jan 24;282(6260):288–291. doi: 10.1136/bmj.282.6260.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blackwell B., Martz B. L. For the first time in man. Clin Pharmacol Ther. 1972 Sep-Oct;13(5):812–826. doi: 10.1002/cpt1972135part2812. [DOI] [PubMed] [Google Scholar]
  5. Freestone S., Silas J. H., Ramsay L. E. Sample size for short-term trials of antihypertensive drugs. Br J Clin Pharmacol. 1982 Aug;14(2):265–268. doi: 10.1111/j.1365-2125.1982.tb01971.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. George C. F. The importance of clinical pharmacology in drug development. Clin Sci (Lond) 1981 Mar;60(3):247–250. doi: 10.1042/cs0600247. [DOI] [PubMed] [Google Scholar]
  7. Glassman A. H., Bigger J. T., Jr Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review. Arch Gen Psychiatry. 1981 Jul;38(7):815–820. doi: 10.1001/archpsyc.1981.01780320095011. [DOI] [PubMed] [Google Scholar]
  8. Hollister L. E., Overall J. E. Experience with a failed postmarketing drug surveillance program. J Clin Pharmacol. 1984 Jan;24(1):3–5. doi: 10.1002/j.1552-4604.1984.tb01807.x. [DOI] [PubMed] [Google Scholar]
  9. Joyce C. R. Placebos and other comparative treatments. Br J Clin Pharmacol. 1982 Mar;13(3):313–318. doi: 10.1111/j.1365-2125.1982.tb01380.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Moir D. C. Clinical pharmacology. Drug monitoring. Br Med J (Clin Res Ed) 1981 Feb 21;282(6264):632–634. doi: 10.1136/bmj.282.6264.632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Orme M. Drug absorption in the gut. Br J Anaesth. 1984 Jan;56(1):59–67. doi: 10.1093/bja/56.1.59. [DOI] [PubMed] [Google Scholar]
  12. Pocock S. J. Current issues in the design and interpretation of clinical trials. Br Med J (Clin Res Ed) 1985 Jan 5;290(6461):39–42. doi: 10.1136/bmj.290.6461.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ryan D. M., Hodges B., Spencer G. R., Harding S. M. Simultaneous comparison of three methods for assessing ceftazidime penetration into extravascular fluid. Antimicrob Agents Chemother. 1982 Dec;22(6):995–998. doi: 10.1128/aac.22.6.995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Schindel L. The placebo dilemma. Eur J Clin Pharmacol. 1978 May 31;13(3):231–235. doi: 10.1007/BF00609988. [DOI] [PubMed] [Google Scholar]
  15. Sharma B. K., Santana I. A., Wood E. C., Walt R. P., Pereira M., Noone P., Smith P. L., Walters C. L., Pounder R. E. Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed) 1984 Sep 22;289(6447):717–719. doi: 10.1136/bmj.289.6447.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sheck L., Cox C., Davis H. T., Trimble A. G., Wardell W. M., Hansen R. Success rates in the United States drug development system. Clin Pharmacol Ther. 1984 Nov;36(5):574–583. doi: 10.1038/clpt.1984.224. [DOI] [PubMed] [Google Scholar]
  17. Strom B. L., Melmon K. L. Can postmarketing surveillance help to effect optimal drug therapy? JAMA. 1979 Nov 30;242(22):2420–2422. [PubMed] [Google Scholar]
  18. Turner P. Long-term assessment of drug safety and efficacy. J R Soc Med. 1984 Feb;77(2):93–94. doi: 10.1177/014107688407700201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Warrington S. J. Noninvasive assessment of the cardiovascular effects of psychotropic drugs. J Clin Psychiatry. 1982 May;43(5 Pt 2):4–7. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES